Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

Corindus Vascular Robotics Launches Extensive Study of Robotic Angioplasty Effectiveness and Safety

September 16, 2013 9:03 am | by Business Wire | News | Comments

Corindus Vascular Robotics, a leading developer of precision vascular robotics, today announced the PRECISION Registry, an ongoing study aimed at collecting data on the patterns of use, safety and effectiveness in the delivery and manipulation of percutaneous coronary intervention (PCI) devices.

Sunshine Heart Implants First Patient in C-Pulse COUNTER HF U.S. Pivotal Trial

September 13, 2013 12:31 pm | by Globe Newswire | News | Comments

Sunshine Heart, Inc. (Nasdaq:SSH) announced today the first patient implant in the Company's U.S. pivotal trial, COUNTER HF. The COUNTER HF study is a prospective, randomized, multi-center, controlled trial that will evaluate the safety and efficacy of the C-Pulse system for the treatment of NYHA Class III and ambulatory Class IV heart failure.

Electronic Smart Pump to Revolutionize Heart Disease Treatment

September 13, 2013 11:19 am | by Nottingham Trent University | News | Comments

A world’s first electronic smart pump which aims to increase the survival chances of victims of chronic heart failure is being developed by researchers at Nottingham Trent University and Nottingham University Hospitals NHS Trust. The smart aortic graft would be implanted into a removed section of the aorta.

Advertisement

The Pulse: Robots Remove Brain Tumors

September 12, 2013 10:12 am | by Eric Sorensen, Coordinator of Multimedia Development | Videos | Comments

On this episode of The Pulse, brought to you by MDT TV, we’re removing brain tumors with robots, using MetaboShield to help obesity, regenerating heart tissue, and pairing glucometers with smartphones for ease of use.      

El Camino Hospital Enrolls Second Patient in Global Clinical Trial Evaluating the Medtronic CoreValve® System in Intermediate Risk Patients with Aortic Valve Disease

September 11, 2013 3:38 pm | by Business Wire | News | Comments

El Camino Hospital, in partnership with the Taft Center for Clinical Research and the Fogarty Clinical Research Institute, both a part of the Fogarty Institute for Innovation, announced today that it has enrolled its second patient in a global clinical trial comparing the Medtronic CoreValve® System with surgical aortic valve replacement in patients with severe aortic stenosis who are at intermediate risk for open-heart surgery.

Existing Equipment Still has Staying Power—Part 1

September 11, 2013 12:13 pm | by George Karalias, Director of Marketing and Communications, Rochester Electronics | Blogs | Comments

Any time a disruptive technology comes along, prior generations of similar technologies are impacted. In the consumer market, customers generally adopt new technology rapidly if the price is right. For higher-value equipment, though, prior generations may find a new lease on life while customers wait until new technology price points come down.

Gore Receives First FDA Approval for Endovascular Repair of Aortic Dissection

September 11, 2013 8:00 am | by Business Wire | News | Comments

W. L. Gore & Associates (Gore) today announced that the US Food and Drug Administration (FDA) has approved the Conformable GORE® TAG® Thoracic Endoprosthesis for endovascular repair of acute and chronic Type B dissections of the descending thoracic aorta.

UK Man Without Human Heart Leaves Papworth Hospital with New Donor Heart

September 10, 2013 2:57 pm | by Bio-Medicine.Org | News | Comments

SynCardia Systems, Inc. announced today that Matthew Green, the UK's 1st patient to be discharged with the SynCardia temporary Total Artificial Heart, has been successfully bridged to transplant after almost two years of support. Green, his wife and their 7-year-old son celebrated his new beginning with a holiday.

Advertisement

CardiacAssist Launches Protek17 Arterial Cannula

September 10, 2013 9:51 am | by Business Wire | News | Comments

CardiacAssist announced the launch of the Protek17 Arterial Cannula, a key component of the TandemHeart temporary circulatory support platform used to rest the heart and circulate blood for patients with severe cardiac dysfunction. Protek17 is designed for improved patient safety and ease of use...

MRI May Predict Heart Attack and Stroke Risk in People with Diabetes

September 10, 2013 9:38 am | by Radiological Society of North America | News | Comments

Whole-body MRI may serve as a valuable noninvasive tool for assessing the risk of heart attack and stroke in diabetic patients, according to a new study published online in the journal Radiology. Diabetes is a metabolic disease characterized by an increased concentration of glucose in the blood.

Sequestration saps 40% of Framingham Heart Study's budget

September 10, 2013 7:29 am | by Mass Device | News | Comments

The famed Framingham Heart Study lost 40% of its budget to sequestration, which means layoffs and closures are on the way for the nation's longest-running cardiovascular disease trial. The study lost $4 million of its annual $9 million budget thanks to automatic funding cuts that took effect amid federal sequestration...

European Launch of New Version of Codman Neuro’s Revive SE Thrombectomy Device for Treatment of Acute Ischemic Stroke

September 9, 2013 2:06 pm | by Codman Neuro | News | Comments

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, announced the European launch of the REVIVE™ SE Thrombectomy Device, a next generation clot removal device offering enhanced navigation through the cerebral vasculature and rapid restoration of blood flow to the brain after an ischemic stroke.

CardioMEMs' 2nd chance with the FDA is good news for backer St. Jude Medical

September 9, 2013 1:17 pm | by Mass Device | News | Comments

Once-rejected CardioMEMs will get another shot at FDA approval for its Champion implantable heart failure monitoring systems when the agency's Circulatory System Devices Panel convenes next month, according to a notice in the Federal Register.  

Advertisement

Synthetic mRNA Can Induce Self-Repair and Regeneration of the Infarcted Heart

September 9, 2013 12:05 pm | by Karolinska Institutet | News | Comments

A team of scientists at Karolinska Institutet and Harvard University has taken a major step towards treatment for heart attack, by instructing the injured heart in mice to heal by expressing a factor that triggers cardiovascular regeneration driven by native heart stem cells.

Intelomed Raises $4M with Series A-1 Round

September 9, 2013 9:00 am | by The Associated Press | News | Comments

Intelomed, Inc., a developer of noninvasive medical devices and technology for monitoring cardiovascular stability, today announced it has secured $4 million in funding from new and existing shareholders through the sale of its Series A-1 Common Preferred stock. 

Keystone Heart's TriGuardT Cerebral Protection Device Receives CE Marking

September 9, 2013 4:15 am | by The Associated Press | News | Comments

Keystone Heart, a leader in the development of cerebral protection devices for interventional cardiology and cardiac surgery procedures, announced today that its TriGuardT Cerebral Protection Device has received CE Marking, enabling the company to commercially market the TriGuard in Europe and other territories.

Meeting Announcement: October 8-9, 2013 Circulatory System Devices Panel of the Medical Devices Advisory Committee

September 9, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments

On both days the committee will discuss, make recommendations, and vote on devices indicated for use in patients with heart failure (HF).  On October 8, 2013, the committee will discuss, make recommendations, and vote on information related to the premarket approval application regarding the expansion of indications supported by the BLOCK HF trial...

ESC 2013: Pacemakers set life expectancy back to normal, researchers say

September 6, 2013 2:29 pm | by Mass Device | News | Comments

A slow heart rhythm puts patients at risk of early death, but a cardiac implant may help reset those odds, according to a Dutch study presented this week at the European Society of Cardiology Congress in Amsterdam. A study of pacemakers in 23 Dutch hospitals found that devices implanted to treat slow heart rhythm helped restore normal life expectancy.

Molecular Beacons Light Path to Cardiac Muscle Repair

September 6, 2013 10:24 am | by Woodruff Health Sciences Center | News | Comments

Pure cardiac muscle cells, ready to transplant into a patient affected by heart disease. That’s a goal for many cardiology researchers working with stem cells. Having a pure population of cardiac muscle cells is essential for avoiding tumor formation after transplantation, but has been technically challenging.

CardioKinetix treats 1st Asian patients with Parachute cardiac implant

September 6, 2013 9:59 am | by Mass Device | News | Comments

Four patients in Kuala Lumpur, Malaysia were successfully treated with CardioKinetix's catheter-based Parachute ventricular partitioning device, the Menlo Park, Calif.-based firm announced late last month. The Parachute device is a minimally invasive catheter-based treatment which separates damaged heart muscle from healthy tissue...

Abbott's Test May Offer More Accurate Diagnosis of Heart Attacks in Women

September 5, 2013 10:41 am | by Abbott | News | Comments

Abbott announced today promising preliminary results from a study presented at the ESC Congress 2013, suggesting that its high sensitive troponin test may help doctors improve the diagnosis and prognosis of patients presenting with symptoms of a heart attack.

Your Finger's Pulse Holds the Key to Your Heart's Health

September 5, 2013 10:28 am | by Jennifer Patterson, University of Iowa | News | Comments

A University of Iowa physiologist has a new technique to measure the stiffness of the aorta, a common risk factor for heart disease. And it can be as simple as measuring the pulse in your finger. The new procedure works by placing an instrument called a transducer on the finger or over the brachial artery...

Heart Imaging Tech lands NIH grant to build "Corelab of the Future"

September 5, 2013 7:29 am | by Mass Device | News | Comments

Durham, N.C.-based Heart Imaging Technologies won a $2.5 million grant from the National Institutes of Health in support of efforts to build a "corelab of the future." HeartIT pioneered the WebPAX system, which the company calls the 1st FDA-approved zero-footprint medical imaging workstation.

Philips signs 10-year imaging tech contract with Dutch teaching hospital

September 4, 2013 2:29 pm | by Mass Device | News | Comments

Technology giant Philips awarded a 10-year contract for continuous access of its ultrasound devices to the cardiology department at Medical Center Leeuwarden, a teaching hospital in the Netherlands. The Dutch hospital will also receive training services and periodic structural upgrades as part of the deal.

Kips Bay Medical Provides Business Update

September 4, 2013 8:30 am | by Business Wire | News | Comments

Manny Villafaña, Chairman and Chief Executive Officer of Kips Bay Medical, Inc., a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS® Mesh, for use in coronary artery bypass grafting surgery (CABG), provided the following business update to Kips Bay shareholders and the financial community.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading